| 000 | 01916 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517174340.0 | ||
| 264 | 0 | _c20180817 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a1473-0766 | ||
| 024 | 7 |
_a10.1080/09513590.2017.1379496 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVanetik, Sharon | |
| 245 | 0 | 0 |
_aDay two post retrieval 1500 IUI hCG bolus, progesterone-free luteal support post GnRH agonist trigger - a proof of concept study. _h[electronic resource] |
| 260 |
_bGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology _cFeb 2018 |
||
| 300 |
_a132-135 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aChorionic Gonadotropin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aFamily Characteristics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFertility Agents, Female _xadministration & dosage |
| 650 | 0 | 4 | _aFertilization in Vitro |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGonadotropin-Releasing Hormone _xagonists |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfertility, Female _xdrug therapy |
| 650 | 0 | 4 | _aInfertility, Male |
| 650 | 0 | 4 |
_aIsrael _xepidemiology |
| 650 | 0 | 4 |
_aLuteal Phase _xdrug effects |
| 650 | 0 | 4 |
_aLuteolysis _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOocyte Retrieval |
| 650 | 0 | 4 |
_aOvarian Hyperstimulation Syndrome _xepidemiology |
| 650 | 0 | 4 |
_aOvulation Induction _xadverse effects |
| 650 | 0 | 4 | _aProof of Concept Study |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk |
| 700 | 1 | _aSegal, Linoy | |
| 700 | 1 | _aBreizman, Tatiana | |
| 700 | 1 | _aKol, Shahar | |
| 773 | 0 |
_tGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology _gvol. 34 _gno. 2 _gp. 132-135 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/09513590.2017.1379496 _zAvailable from publisher's website |
| 999 |
_c27587982 _d27587982 |
||